Answers are grounded in this paper and cite their sources.
Cellular senescence is currently one of the dominant concepts of aging. Some cells in developing tissues (prenatal histogenesis) and definitive tissues acquire of morphofunctional changes associated with an increase in size, the formation of special areas of heterochromatin, the formation of a secretory phenotype with the production of proinflammatory cytokines, β-galactosidase, TGFβ, etc. in combination with the blocking of mitosis due to active transcription of р16INK4A, p21CIP1. It is assumed that such cells, called senescent, are not a transitional form in histogenesis from an actively functioning component of differon to cells dying by programmed types of cell death, but a separate functional stage of cytogenesis. The histogenetic significance of such cells in physiological and reparative regeneration in various tissues, as well as their effect on histophysiology, requires further study. Pharmacological elimination of senescent cells in tissues is an actively developing section of anti-aging therapy.
No takes yet. Share an insight, caveat, or question.
Deev et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: